Clinical Trials Logo

Filter by:
NCT ID: NCT04661306 Completed - Cancer Clinical Trials

The Better Sleep for Supporters With Insomnia Study

BeSSI
Start date: September 30, 2020
Phase: N/A
Study type: Interventional

This study will identify whether - and if so, how - tailoring would increase adoption of and benefit from an interactive internet intervention for insomnia called SHUTi (Sleep Healthy Using the Internet) for cancer caregivers. Participating caregivers' sleep and sleep-related characteristics will be characterized from a baseline assessment; then, caregivers will receive complementary and voluntary access to SHUTi. Among caregivers who choose to use SHUTi, intervention use, perceived appropriateness, and effects on sleep and quality of life will be assessed. Among caregivers who choose not to use SHUTi, reasons and barriers to using the intervention will be assessed.

NCT ID: NCT04661267 Completed - Knee Osteoarthritis Clinical Trials

Randomized Trial of Regenexx Stem Cell Support Formula

Start date: February 3, 2021
Phase: N/A
Study type: Interventional

Regenexx, LLC developed a nutritional supplement formula containing many components related to supporting healthy joints This oral, liquid supplement is intended to help improve joint and cartilage health while also increasing their joint function. The goal of this study is to measure changes in joint health and function for patients with knee OA taking this supplement for 2 months.

NCT ID: NCT04661241 Completed - Parkinson's Disease Clinical Trials

Mapping the Target for the MRgFUS Treatment of Tremor

Start date: September 10, 2020
Phase: N/A
Study type: Interventional

The purpose of this investigation is to determine the optimal DRT/VIM target location and its safety margins based on MR-SISET imaging features by comparing with postoperative lesions and clinical outcomes in patients with tremor who will undergo the MRgFUS tremor therapy.

NCT ID: NCT04660890 Completed - Healthy Clinical Trials

A Study of the Cardiac Effects of ALXN2050 in Healthy Adults

Start date: December 12, 2020
Phase: Phase 1
Study type: Interventional

This is a randomized, double-blind, double-dummy, placebo- and positive-controlled parallel study to evaluate the effect of ALXN2050 on the QT interval in healthy adult participants.

NCT ID: NCT04660877 Completed - Healthy Clinical Trials

Blood and Muscle Response to Cheddar Cheese in Healthy Adults

Start date: June 28, 2018
Phase: N/A
Study type: Interventional

The goal of this project is to use a cross over design in young healthy male and female adults: 1. To determine the amino acid blood response to the acute ingestion of cheddar cheese in comparison to that of milk. 2. To determine the muscle mTORC1 response to the acute ingestion of cheddar cheese in comparison to that of milk.

NCT ID: NCT04660851 Completed - Dietary Habits Clinical Trials

Improving Diet Protein Intake in Middle-aged Women

Start date: June 26, 2019
Phase: N/A
Study type: Interventional

The study sought to examine the effectiveness of nutrition education with and without diet coaching on dietary protein intake and muscle mass, strength and function among a group of middle-aged women.

NCT ID: NCT04660721 Completed - Hemostasis Clinical Trials

A Study Evaluating the Safety and Preliminary Efficacy of sFilm-FS in Controlling Parenchymal Bleeding During Elective Hepatic Surgery

Start date: May 12, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

The Study investigates a new product, sFilm-FS, aimed to help controlling body fluid leakage in general surgery procedures, proposing its use as an adjunct to hemostasis and/or sealing.

NCT ID: NCT04660643 Completed - Obesity Clinical Trials

A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss

SURMOUNT-4
Start date: March 29, 2021
Phase: Phase 3
Study type: Interventional

This was a study of tirzepatide in participants with obesity or overweight. The main purpose was to learn more about how tirzepatide maintained body weight loss. The study had two phases: a lead-in phase in which all participants took tirzepatide and a treatment phase in which participants either continued tirzepatide or switched to placebo. The study lasted about 2 years (25 visits).

NCT ID: NCT04660552 Completed - Clinical trials for Autism Spectrum Disorder

Transcranial Photobiomodulation for Reducing Autism Symptoms in Children

TPBMASD
Start date: November 15, 2020
Phase: N/A
Study type: Interventional

The hypothesis of the study is that photobiomodulation reduces symptoms of autism. Participants will be children between the ages of 2 and 6, who have been diagnosed with moderate to severe autism. Transcranial photobiomodulation will be administered to the children in the experimental condition twice a week for 8 weeks. Results will be measured through parental interviews, standardized CARS2 (Childhood Autism Rating Scales, 2nd Edition) and data collected from EEG.

NCT ID: NCT04660539 Completed - Clinical trials for Neuromyelitis Optica Spectrum Disorder

A Study to Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD)

Start date: March 2, 2021
Phase: Phase 3
Study type: Interventional

This multicenter, single-arm, open-label study will evaluate the long-term safety and efficacy of satralizumab in participants with neuromyelitis optica spectrum disorder (NMOSD) who completed open-label extension (OLE) period of studies BN40898 and BN40900. Participants will receive satralizumab as monotherapy or in combination with one of the following background immunosuppressive treatments: azathioprine (AZA), mycophenolate mofetil (MMF), or oral corticosteroids.